Excalibur Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $324K | Hold |
799
| – | – | 0.12% | 129 |
|
|
2025
Q1 | $398K | Hold |
799
| – | – | 0.16% | 116 |
|
|
2024
Q4 | $416K | Sell |
799
-35
| -4% | -$18.2K | 0.17% | 109 |
|
|
2024
Q3 | $516K | Sell |
834
-12
| -1% | -$7.42K | 0.2% | 98 |
|
|
2024
Q2 | $468K | Sell |
846
-10
| -1% | -$5.53K | 0.19% | 103 |
|
|
2024
Q1 | $498K | Buy |
856
+8
| +0.9% | +$4.65K | 0.21% | 99 |
|
|
2023
Q4 | $450K | Sell |
848
-68
| -7% | -$36.1K | 0.21% | 98 |
|
|
2023
Q3 | $464K | Buy |
916
+10
| +1% | +$5.06K | 0.24% | 94 |
|
|
2023
Q2 | $473K | Hold |
906
| – | – | 0.24% | 91 |
|
|
2023
Q1 | $522K | Sell |
906
-10
| -1% | -$5.76K | 0.27% | 88 |
|
|
2022
Q4 | $504K | Sell |
916
-10
| -1% | -$5.51K | 0.26% | 87 |
|
|
2022
Q3 | $470K | Hold |
926
| – | – | 0.26% | 86 |
|
|
2022
Q2 | $503K | Hold |
926
| – | – | 0.26% | 90 |
|
|
2022
Q1 | $547K | Sell |
926
-3
| -0.3% | -$1.77K | 0.24% | 92 |
|
|
2021
Q4 | $620K | Sell |
929
-114
| -11% | -$76.1K | 0.25% | 91 |
|
|
2021
Q3 | $596K | Hold |
1,043
| – | – | 0.26% | 87 |
|
|
2021
Q2 | $526K | Sell |
1,043
-5
| -0.5% | -$2.52K | 0.24% | 91 |
|
|
2021
Q1 | $478K | Hold |
1,048
| – | – | 0.24% | 89 |
|
|
2020
Q4 | $488K | Hold |
1,048
| – | – | 0.26% | 80 |
|
|
2020
Q3 | $463K | Hold |
1,048
| – | – | 0.28% | 73 |
|
|
2020
Q2 | $380K | Sell |
1,048
-3
| -0.3% | -$1.09K | 0.25% | 75 |
|
|
2020
Q1 | $298K | Buy |
1,051
+6
| +0.6% | +$1.7K | 0.23% | 77 |
|
|
2019
Q4 | $339K | Buy |
+1,045
| New | +$339K | 0.22% | 78 |
|